Wearable Heart Monitoring Devices Market Size is valued at USD 3.0 Bn in 2024 and is predicted to reach USD 24.7 Bn by the year 2034 at a 23.4% CAGR during the forecast period for 2025-2034.
Wearable heart monitoring technologies possess significant utility for persons seeking to monitor their cardiovascular well-being, enhance their physical fitness, and adopt a more engaged way of life. These devices offer valuable information regarding heart rate patterns, levels of physical activity, and sleep habits, empowering individuals to make well-informed choices regarding their overall health and wellness.
The increased prevalence of heart failure, expanding awareness of wearables-based cardiac monitoring, and technological developments in wearable devices are all driving market expansion. According to the CDC update issued in October 2022, coronary heart disease is the most frequent type of heart disease, with around 20.1 Bn persons aged 20 and older suffering from coronary artery disease (roughly 7.2%). As a result, the high prevalence of coronary artery disease is propelling market expansion.
Furthermore, more than 100,000 Canadians are diagnosed with heart failure yearly, according to the 2022 Spotlight on Heart Failure report. According to the same report, heart failure will cost Canada more than USD 2.8 billion annually. As a result of the rising number of cases of heart failure and rising healthcare costs, heart monitoring devices based on wearable technology are required to cut costs and improve heart monitoring.
The Wearable Heart Monitoring Devices market has been segmented based on Product, Application and End-User. The Product segment comprises Chest Straps & Patches, Pulse Oximeters, Blood Pressure Monitors, Smartwatches, Others (Wrist Monitors, ECG Finger Sensors, etc.), Whereas the Application segment includes Healthcare Monitoring, Consumer Wellness, Others (Research, etc.). At last, By End-user, the market is divided into Hospitals, Specialty Centers, Academic & Research Institutes, Home Use, and Others (Ambulatory Service Centers, Nursing Homes, etc.).
This segment is likewise expected to grow at the fastest rate over the projection period. Factors such as technological breakthroughs in wearables, and a greater emphasis on allowing public access are all contributing factors.
Wearable cardiac monitoring devices provide remote patient monitoring, allowing healthcare providers to track patients' heart health in real-time and therefore driving market growth. As a result, the increase in patient compliance is predicted to drive the wearable heart monitoring devices market size in the coming years.
North America is expected to account for a sizable portion of the market for wearable heart monitoring devices. This is because of reasons such as increased CVD rates and the existence of significant market competitors and their strategic activities. According to the CARES 2021 annual report, 62.5% of males in the United States had Out-Of-Hospital Cardiac Arrest (OHCA). According to the same source, 97.6% of adults and 2.4% of children in the United States will have OHCA by 2021. As the frequency of cardiac issues rises, so will the need for wearable heart monitoring devices, driving market expansion throughout the forecast period.
| Report Attribute | Specifications |
| Market size value in 2024 | USD 3.0 Bn |
| Revenue forecast in 2034 | USD 24.7 Bn |
| Growth rate CAGR | CAGR of 23.4% from 2025 to 2034 |
| Quantitative units | Representation of revenue in US$ Bn and CAGR from 2025 to 2034 |
| Historic Year | 2021 to 2024 |
| Forecast Year | 2025-2034 |
| Report coverage | The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
| Segments covered | By Product, Application, End-User |
| Regional scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
| Country scope | U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; South Korea; South East Asia |
| Competitive Landscape | Zoll Medical Corporation, Cardiac Rhythm, iRhythm Technologies Inc., Proteus Digital Health, Custo Med GmbH, Nuubo, Medtronic plc, Koninklijke Philips N.V. (BioTelemetry, Inc.), Boston Scientific (Preventice Solutions, Inc.), Baxter, Braemar Manufacturing, LLC, Cardiac Science Corporation, Nihon Kohden Corporation, General Electric Company, Schiller, Abiomed, Biotronik, Inc. |
| Customization scope | Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
| Pricing and available payment methods | Explore pricing alternatives that are customized to your particular study requirements. |
Wearable Heart Monitoring Devices Market By Product
Wearable Heart Monitoring Devices Market By Application
Wearable Heart Monitoring Devices Market By End-user
Wearable Heart Monitoring Devices Market By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
This study employed a multi-step, mixed-method research approach that integrates:
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Secondary data for the market study was gathered from multiple credible sources, including:
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Primary interviews for this study involved:
Interviews were conducted via:
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
This ensured that the dataset used for modelling was clean, robust, and reliable.
The bottom-up approach involved aggregating segment-level data, such as:
This method was primarily used when detailed micro-level market data were available.
The top-down approach used macro-level indicators:
This approach was used for segments where granular data were limited or inconsistent.
To ensure accuracy, a triangulated hybrid model was used. This included:
This multi-angle validation yielded the final market size.
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Given inherent uncertainties, three scenarios were constructed:
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.